Study of a large cohort of PD patients in Italy finds COVID‐19 risk and mortality similar to those in the general population, but symptoms perhaps milder



Background: It is unknown whether patients with PD are at greater risk of COVID-19, what their risk factors are, and whether their clinical manifestations differ from the general population.

Objectives: The study aimed to address all these issues.

Want to read more?

Log in or sign up to access all Neurodiem content.

Already have an account? Log In

© 2020 International Parkinson and Movement Disorder Society